Taiyen Biotech Co., Ltd.

Informe acción TWSE:1737

Capitalización de mercado: NT$6.5b

Salud financiera de hoja de balance de Taiyen Biotech

Salud financiera controles de criterios 5/6

Taiyen Biotech tiene un patrimonio de accionistas total de NT$6.6B y una deuda total de NT$194.8M, lo que sitúa su ratio deuda-patrimonio en 3%. Sus activos y pasivos totales son NT$8.2B y NT$1.7B respectivamente. El BAIT de Taiyen Biotech es de NT$303.5M, por lo que su ratio de cobertura de intereses es de -9.7. Tiene efectivo e inversiones a corto plazo que ascienden a NT$1.8B.

Información clave

3.0%

Ratio deuda-patrimonio

NT$194.84m

Deuda

Ratio de cobertura de intereses-9.7x
EfectivoNT$1.78b
PatrimonioNT$6.55b
Total pasivoNT$1.68b
Activos totalesNT$8.23b

Actualizaciones recientes sobre salud financiera

Recent updates

Taiyen Biotech's (TWSE:1737) Dividend Will Be Reduced To NT$1.20

Jul 31
Taiyen Biotech's (TWSE:1737) Dividend Will Be Reduced To NT$1.20

Investors Can Find Comfort In Taiyen Biotech's (TWSE:1737) Earnings Quality

May 09
Investors Can Find Comfort In Taiyen Biotech's (TWSE:1737) Earnings Quality

Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet

Apr 24
Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet

Taiyen Biotech's (TPE:1737) Returns On Capital Are Heading Higher

Apr 09
Taiyen Biotech's (TPE:1737) Returns On Capital Are Heading Higher

A Look At The Intrinsic Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

Mar 25
A Look At The Intrinsic Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

Is Taiyen Biotech Co., Ltd. (TPE:1737) Popular Amongst Institutions?

Mar 12
Is Taiyen Biotech Co., Ltd. (TPE:1737) Popular Amongst Institutions?

Taiyen Biotech Co., Ltd. (TPE:1737) Stock's On A Decline: Are Poor Fundamentals The Cause?

Feb 14
Taiyen Biotech Co., Ltd. (TPE:1737) Stock's On A Decline: Are Poor Fundamentals The Cause?

Taiyen Biotech Co., Ltd. (TPE:1737) Investors Should Think About This Before Buying It For Its Dividend

Feb 01
Taiyen Biotech Co., Ltd. (TPE:1737) Investors Should Think About This Before Buying It For Its Dividend

Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly

Jan 17
Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly

Returns On Capital - An Important Metric For Taiyen Biotech (TPE:1737)

Jan 04
Returns On Capital - An Important Metric For Taiyen Biotech (TPE:1737)

A Look At The Fair Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

Dec 22
A Look At The Fair Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

How Much Of Taiyen Biotech Co., Ltd. (TPE:1737) Do Institutions Own?

Dec 09
How Much Of Taiyen Biotech Co., Ltd. (TPE:1737) Do Institutions Own?

Shareholders Of Taiyen Biotech (TPE:1737) Must Be Happy With Their 53% Return

Nov 24
Shareholders Of Taiyen Biotech (TPE:1737) Must Be Happy With Their 53% Return

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (NT$2.8B) de 1737 superan a sus pasivos a corto plazo (NT$1.0B).

Pasivo a largo plazo: Los activos a corto plazo de 1737 (NT$2.8B) superan a sus pasivos a largo plazo (NT$653.6M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: 1737 tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de 1737 ha crecido de 0.3% a 3% en los últimos 5 años.

Cobertura de la deuda: La deuda de 1737 está bien cubierta por el flujo de caja operativo (272.4%).

Cobertura de intereses: 1737 gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.


Hoja de balance


Descubre empresas con salud financiera